Article Cited by others

COMMENTARY

What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials

Kaur Rimplejeet, Sidhu Preeti, Singh Surjit

Year : 2016| Volume: 7| Issue : 3 | Page no: 120-126

   This article has been cited by
 
1 Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Carina Hasenoehrl,Martin Storr,Rudolf Schicho
Expert Review of Gastroenterology & Hepatology. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinsonęs disease
Noemi Pasquarelli,Christoph Porazik,Hanna Bayer,Eva Buck,Stefan Schildknecht,Patrick Weydt,Anke Witting,Boris Ferger
Neurochemistry International. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 The cannabinoid system and pain
Stephen G. Woodhams,Victoria Chapman,David P. Finn,Andrea G. Hohmann,Volker Neugebauer
Neuropharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article